Home › Funds › PFIZER INC › ZNTL
PFIZER INC position in ZNTL
ZENTALIS PHARMACEUTICALS INC · Health Care
PFIZER INC reported holding 953,834 shares of ZNTL (ZENTALIS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.6M, representing 1.57% of its reported portfolio and ranking #12 among its reported holdings. PFIZER INC has disclosed ZNTL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How PFIZER INC's ZNTL position evolved
PFIZER INC first disclosed a stake in ZNTL in Q4 2024 at 953,834 shares (US$2.9M). The position peaked in Q2 2026 at 953,834 shares, worth US$3.9M. Across 8 filings, PFIZER INC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 953,834 shares valued at US$2.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 953.83K | $2.89M | New |
| Q1 2025 | 953.83K | $1.52M | Hold |
| Q2 2025 | 953.83K | $1.11M | Hold |
| Q3 2025 | 953.83K | $1.44M | Hold |
| Q4 2025 | 953.83K | $1.29M | Hold |
| Q1 2026 | 953.83K | $2.00M | Hold |
| Q2 2026 | 953.83K | $3.85M | Hold |
| Q3 2026 | 953.83K | $2.58M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZNTL and 13F data
ZNTL (ZENTALIS PHARMACEUTICALS INC) is a Health Care company. 29 other funds we track also report a position in ZNTL — the largest reported positions include 5AM Venture Management, LLC (US$19.1M), Opaleye Management Inc. (US$6.9M), Decheng Capital LLC (US$6.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZNTL
- 5AM Venture Management, LLC 3.95M sh · $19.15M · Q2 2026
- Opaleye Management Inc. 1.41M sh · $6.85M · Q2 2026
- Decheng Capital LLC 1.32M sh · $6.42M · Q2 2026
- Ishara Investments LP 1.02M sh · $4.97M · Q2 2026
- Squadron Capital Management LLC 426.00K sh · $2.07M · Q2 2026
FAQ
How long has PFIZER INC held ZNTL?
PFIZER INC has disclosed ZNTL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is PFIZER INC's current position in ZNTL?
As of Q3 2026, PFIZER INC holds 953.83K shares of ZNTL (ZENTALIS PHARMACEUTICALS INC), valued at $2.58M, representing 1.57% of its reported portfolio and ranking #12.
Has PFIZER INC been buying or selling ZNTL?
In the latest 13F filing (Q3 2026), PFIZER INC held unchanged its position in ZNTL. The position peaked in Q2 2026 at 953.83K shares.
Which other funds hold ZNTL?
Other major institutional holders of ZNTL include 5AM Venture Management, LLC, Opaleye Management Inc., Decheng Capital LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.